Profile: AIG Life's CEO Adam Winslow

FM: We've seen a lot of change from AIG in critical illness with the likes of Key 3 so can you tell me about your thinking in that and what we can expect next in terms of innovation? AW: We are an agile, innovative company but it's always helpful to have some proof to back up statements like that, so Key 3 was an innovation for us. I don't just see [innovation] as about products; it could be about the platform used, it could be about systems, it could be about pricing or it could be sales and marketing, collateral and support. With Key 3, we noticed there was a market decline in CI...